P462: IDENTIFICATION OF TARGETED THERAPIES DIRECTED TO ACUTE MYELOID LEUKEMIA MINIMAL RESIDUAL DISEASE

• N. van Gils,
• F. Kessler,
• M. Broux,
• F. Denkers,
• S. Demeyer,
• J. Cools,
• D. C. De Leeuw,
• J. Janssen,
• L. Smit

Affiliations

N. van Gils

1 Hematology, UMC Amsterdam, location VUmc, Cancer Center Amsterdam, Amsterdam, Netherlands

F. Kessler

1 Hematology, UMC Amsterdam, location VUmc, Cancer Center Amsterdam, Amsterdam, Netherlands

M. Broux

2 Center for Human Genetics, KU Leuven, Leuven, Belgium

F. Denkers

1 Hematology, UMC Amsterdam, location VUmc, Cancer Center Amsterdam, Amsterdam, Netherlands

S. Demeyer

2 Center for Human Genetics, KU Leuven, Leuven, Belgium

J. Cools

2 Center for Human Genetics, KU Leuven, Leuven, Belgium

D. C. De Leeuw

1 Hematology, UMC Amsterdam, location VUmc, Cancer Center Amsterdam, Amsterdam, Netherlands

J. Janssen

1 Hematology, UMC Amsterdam, location VUmc, Cancer Center Amsterdam, Amsterdam, Netherlands

L. Smit

1 Hematology, UMC Amsterdam, location VUmc, Cancer Center Amsterdam, Amsterdam, Netherlands